Binovi Technologies Corp. (BNVIF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Binovi Technologies Corp. (BNVIF) trades at $0.00 with AI Score 54/100 (Grade B). Binovi Technologies Corp. Market cap: $13,307, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for BNVIF: BNVIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BNVIF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
BNVIF: the 6 perspectives are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →Binovi Technologies Corp. (BNVIF) Healthcare & Pipeline Overview
Binovi Technologies Corp. specializes in developing and commercializing visual and neuro-cognitive processing solutions, including hardware and software, to diagnose and remediate visual perception disorders. Operating across Canada, the U.S., and internationally, the company offers a suite of products like Binovi Touch, Pro, and Coach, targeting vision therapy and training markets.
What Is the Investment Thesis for BNVIF?
Binovi Technologies Corp. operates within the specialized and growing segment of visual and neuro-cognitive processing, offering a suite of hardware and software solutions for diagnosing and remediating visual perception disorders. The company's gross margin of 70.7% indicates strong product-level profitability, despite a negative profit margin of -8790.2% reflecting significant operational expenses relative to revenue. A key value driver is the ongoing development of Binovi Agile and Binovi Connect, the latter being a web-based video conferencing solution that could expand market access by connecting consumers directly with vision care professionals, particularly relevant in the current healthcare landscape. The company's established product ecosystem, including Binovi Touch, Pro, Coach, and Academy, provides a foundation for recurring revenue streams through subscriptions or service agreements. Geographic expansion across Canada, the U.S., and internationally further broadens its potential customer base. However, the company's small size, with only 7 employees, and its OTC market listing as "OTC Other" with unknown disclosure status, present inherent risks regarding operational scale, funding, and transparency. Future growth hinges on successful commercialization of its development pipeline, effective market penetration, and managing its high negative profit margin towards profitability.
Based on FMP financials and quantitative analysis
BNVIF Key Highlights
- Gross Margin of 70.7% indicates strong profitability at the product level.
- Negative Profit Margin of -8790.2% reflects substantial operational costs relative to current revenue generation.
- Beta of 0.14 suggests low volatility relative to the broader market.
- Development of Binovi Connect, a web-based video conferencing solution, aims to expand reach to vision care professionals and consumers.
- Operates internationally, serving markets in Canada, the United States, and other global regions.
Who Are BNVIF's Competitors?
BNVIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.34 | -3.16% | $308.28M | 70 |
| HNGE Hinge Health, Inc. | $84.05 | -1.20% | $6.50B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| CRVW CareView Communications, Inc. | $0.06 | +0.00% | $35.03M | 54 |
| CDXFF Cloud DX Inc. | $0.09 | +12.50% | $9.75M | 54 |
| SLGCW SomaLogic, Inc. | $0.09 | -28.33% | $396.23M | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BNVIF's Key Strengths?
- Specialized product suite for visual and neuro-cognitive processing disorders.
- Strong gross margin of 70.7% on products.
- Integrated hardware and software ecosystem (Touch, Pro, Coach, Academy).
- International market presence (Canada, U.S., and other regions).
What Are BNVIF's Weaknesses?
- Significant negative profit margin (-8790.2%) indicating high operating costs relative to revenue.
- Small employee base (7 employees) potentially limiting scalability and operational capacity.
- OTC market listing as "OTC Other" with unknown disclosure status, impacting investor confidence and liquidity.
- Limited public financial transparency due to OTC status.
What Could Drive BNVIF Stock Higher?
- Successful commercialization and market adoption of Binovi Connect, the web-based video conferencing solution, expanding telehealth capabilities.
- Launch of Binovi Agile, indicating continued product innovation and potential for new revenue streams.
- Expansion of the company's international footprint beyond its current presence in Canada and the U.S.
- Strategic partnerships or distribution agreements that enhance market reach for its visual and neuro-cognitive processing products.
What Are the Key Risks for BNVIF?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant negative profit margin of -8790.2% indicates substantial operational losses, posing a going concern risk if not addressed.
- Limited public disclosure and "Unknown" disclosure status on the OTC market may deter institutional investors and impact capital raising efforts.
- Intense competition from larger, better-funded companies in the broader healthcare technology and medical device sectors.
- Small employee base (7 employees) may limit the company's capacity for rapid scaling, extensive R&D, and comprehensive market penetration.
- Reliance on successful development and commercialization of new products, where delays or market rejection could impact growth.
What Are the Growth Opportunities for BNVIF?
- Expansion of Telehealth Solutions with Binovi Connect: The development of Binovi Connect, a web-based video conferencing solution, presents a significant growth opportunity. This platform aims to directly connect consumers with vision care professionals, tapping into the rapidly expanding telehealth market. The global telehealth market size was estimated at over $80 billion in 2022 and is projected to grow substantially, driven by convenience, accessibility, and technological advancements. By offering a specialized telehealth solution for visual care, Binovi can broaden its customer base beyond traditional clinics, reaching underserved populations and individuals seeking remote consultations and therapy, potentially increasing recurring revenue streams from subscriptions or usage fees. This could significantly expand its market reach within the next 3-5 years.
- Increased Penetration in Professional Vision Care Markets: Binovi's existing products like Binovi Pro and Binovi Touch are designed for doctors and trainers. There is an ongoing opportunity to increase market penetration within optometry clinics, ophthalmology practices, sports vision training centers, and educational institutions. The global vision care market is substantial, with millions of professionals seeking advanced tools for diagnosis and therapy. By enhancing sales and marketing efforts, providing robust professional training, and demonstrating clinical efficacy, Binovi can secure more partnerships and adoptions within these professional segments. This strategy focuses on expanding its footprint in established clinical settings, leveraging the credibility of its existing product suite over the next 2-4 years.
- Commercialization of Binovi Agile and Future Product Development: The company has Binovi Agile under development, indicating a continuous innovation pipeline. Successful commercialization of new and improved hardware or software products can open new revenue streams and enhance the company's competitive edge. Investing in research and development to address evolving needs in visual and neuro-cognitive health can lead to market leadership in specific niches. The market for specialized medical devices and software is constantly innovating, and bringing new, effective solutions to market can capture significant value. This ongoing innovation cycle is critical for sustained growth and market relevance, with new product launches potentially occurring within the next 1-3 years.
- International Market Expansion Beyond Current Footprint: While Binovi already operates in Canada, the U.S., and internationally, there is significant potential to deepen its presence in existing international markets and enter new ones. Many countries have growing healthcare expenditures and increasing demand for advanced visual health solutions. Strategic partnerships with international distributors, local healthcare providers, or government initiatives could facilitate this expansion. The global market for vision care products and services is valued in the hundreds of billions, offering ample room for growth for specialized providers. Tailoring products to local regulatory requirements and cultural contexts can unlock substantial untapped markets over the next 5-7 years.
- Leveraging Binovi Academy for Educational and Professional Development: Binovi Academy, an educational hub, can be leveraged not just as a support tool but as a revenue-generating platform for professional development and certification programs. Offering accredited courses or specialized training modules on visual therapy and neuro-cognitive training using Binovi's tools could attract a broader audience of professionals seeking to enhance their skills. This creates an additional revenue stream and strengthens the company's brand as an authority in the field. The market for professional medical education and certifications is robust, and a well-developed academy can foster a community of users and advocates, driving product adoption and loyalty over the medium term (2-5 years).
What Opportunities Does BNVIF Have?
- Expansion into telehealth with Binovi Connect, tapping into a growing market.
- Increased market penetration in professional vision care and sports training.
- Commercialization of new products like Binovi Agile.
- Deepening presence in existing international markets and entering new ones.
What Threats Does BNVIF Face?
- Intense competition from larger medical device and digital health companies.
- Regulatory hurdles and compliance costs in healthcare technology.
- Dependence on successful commercialization of new products.
- Funding challenges due to small market capitalization and negative profitability.
What Are BNVIF's Competitive Advantages?
- Specialized focus on visual and neuro-cognitive processing disorders, creating a niche market expertise.
- Integrated suite of hardware and software products, offering a comprehensive solution from diagnosis to therapy.
- Proprietary technology embedded in products like Binovi Touch and Binovi Pro.
- Established international presence in Canada, the U.S., and other markets.
- Ongoing product development pipeline, including Binovi Agile and Binovi Connect, indicating continuous innovation.
What Does BNVIF Do?
Binovi Technologies Corp., headquartered in Vancouver, Canada, is a specialized company focused on the development, manufacturing, and commercialization of advanced visual and neuro-cognitive processing products. The company's core mission revolves around providing innovative hardware and software solutions designed to diagnose and remediate various visual perception disorders. Initially known as Eyecarrot Innovations Corp., the company rebranded to Binovi Technologies Corp. in June 2020, reflecting its evolving strategic focus and product portfolio. Binovi's product ecosystem is comprehensive, catering to both professionals and end-users. Key offerings include Binovi Touch, a dedicated tool engineered for vision therapy and training applications, enabling precise and interactive exercises. Binovi Pro serves as a robust management platform, empowering doctors and trainers to efficiently oversee patient and athlete vision training regimens, track progress meticulously, and design and assign customized protocols. Complementing this, Binovi Coach provides users with clear, multimedia-guided activities, facilitating adherence and effectiveness in their assigned training programs. Furthermore, Binovi Academy functions as an educational hub, offering resources and knowledge pertinent to visual and neuro-cognitive health. The company extends its market reach across Canada, the United States, and internationally, aiming to address a broad spectrum of visual health needs. Binovi also maintains a pipeline of products under development, including Binovi Agile, which suggests future enhancements in its core offerings, and Binovi Connect, a web-based video conferencing solution designed to bridge the gap between consumers and vision care professionals, indicating a strategic move towards telehealth and remote care integration within its specialized niche. This integrated approach positions Binovi Technologies Corp. as a provider of comprehensive solutions in the visual and neuro-cognitive health sector.
What Products and Services Does BNVIF Offer?
- Develops and manufactures hardware for visual and neuro-cognitive processing.
- Creates software solutions for diagnosing visual perception disorders.
- Commercializes products for remediating visual perception disorders.
- Offers Binovi Touch for vision therapy and training exercises.
- Provides Binovi Pro for doctors and trainers to manage patient regimens and track progress.
- Supplies Binovi Coach for users to complete assigned activities with multimedia guidance.
- Maintains Binovi Academy as an educational resource for visual health.
- Developing Binovi Connect, a web-based video conferencing tool for connecting consumers with vision care professionals.
How Does BNVIF Make Money?
- Sells specialized hardware products like Binovi Touch for vision therapy.
- Generates revenue through software subscriptions or licenses for platforms like Binovi Pro and Binovi Coach.
- Potentially earns revenue from professional services, training, and educational content via Binovi Academy.
- Aims to create new revenue streams from its developing telehealth solution, Binovi Connect, possibly through usage fees or premium access.
- Operates in Canada, the United States, and other international markets.
What Industry Does BNVIF Operate In?
Binovi Technologies Corp. operates within the Medical - Healthcare Information Services industry, a segment of the broader Healthcare sector focused on leveraging technology for improved patient care and operational efficiency. This industry is experiencing significant growth driven by increasing demand for specialized diagnostic and therapeutic tools, particularly in neuro-cognitive and visual health. Market trends indicate a shift towards integrated digital health solutions, remote patient monitoring, and personalized medicine, areas where Binovi's hardware and software products align. The competitive landscape includes both established medical device manufacturers and emerging tech companies offering digital health platforms. Binovi differentiates itself by focusing specifically on visual perception disorders with a comprehensive suite of tools from diagnosis to training. The demand for such specialized solutions is fueled by a growing awareness of visual and cognitive health issues, coupled with an aging global population and increased screen time, which can contribute to various visual challenges. Binovi's position is as a niche provider, aiming to capture market share through its specialized product offerings and developing telehealth capabilities.
Who Are BNVIF's Key Customers?
- Optometrists and ophthalmologists seeking diagnostic and therapeutic tools.
- Vision therapists and trainers managing patient and athlete regimens.
- Athletes and individuals undergoing vision training.
- Consumers seeking remote visual care consultations via future Binovi Connect.
- Educational institutions utilizing visual and neuro-cognitive training programs.
F-Score 2/9Financial Health
Binovi Technologies Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Binovi Technologies Corp. (BNVIF) Valuation Context
Valued at 13K, BNVIF is classified as a micro-cap stock. Relative to its peer group, BNVIF's quantitative score of 54/100 is below the peer average of 65/100.
Company Profile
Binovi Technologies Corp. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Jatinder Dhaliwal. BNVIF has traded publicly since 2017.
BNVIF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized product suite for visual and neuro-cognitive processing disorders.
- Strong gross margin of 70.7% on products.
- Integrated hardware and software ecosystem (Touch, Pro, Coach, Academy).
- International market presence (Canada, U.S., and other regions).
Bear Case
- Significant negative profit margin (-8790.2%) indicating high operating costs relative to revenue.
- Small employee base (7 employees) potentially limiting scalability and operational capacity.
- OTC market listing as "OTC Other" with unknown disclosure status, impacting investor confidence and liquidity.
- Limited public financial transparency due to OTC status.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
BNVIF Latest News
No recent news available for BNVIF.
BNVIF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BNVIF.
Price Targets
Wall Street price target analysis for BNVIF.
BNVIF MoonshotScore
What does this score mean?
The MoonshotScore rates BNVIF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Jatinder Dhaliwal
Chief Executive Officer
Jatinder Dhaliwal serves as the Chief Executive Officer of Binovi Technologies Corp. While specific details regarding his prior career history, educational background, and previous roles are not provided in the available source data, his leadership is central to the company's operations. He is responsible for managing the company's small team of 7 employees, overseeing the strategic direction and daily execution of its initiatives in visual and neuro-cognitive processing solutions. His role encompasses guiding the development, manufacturing, and commercialization efforts across Canada, the United States, and internationally.
Track Record: The specific track record of key achievements and strategic decisions under Jatinder Dhaliwal's leadership is not detailed in the provided information. However, his tenure includes the company's rebranding from Eyecarrot Innovations Corp. to Binovi Technologies Corp. in June 2020, a strategic move to align the corporate identity with its evolving product focus. He oversees the ongoing development of new products like Binovi Agile and Binovi Connect, which are critical for the company's future growth trajectory.
BNVIF OTC Market Information
Binovi Technologies Corp. trades on the OTC market under the 'OTC Other' tier. This classification signifies that the company does not meet the disclosure or financial standards required for listing on higher OTC tiers like OTCQX or OTCQB, nor on major exchanges such as the NYSE or NASDAQ. Companies in the 'OTC Other' tier typically provide limited public information, often not filing with the SEC, which can result in less transparency compared to fully reporting companies. This tier is generally associated with companies that are either very small, distressed, or choose not to comply with higher disclosure requirements, making it a more speculative segment of the market for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and unknown disclosure status, hindering informed investment decisions.
- Potential for significant price volatility due to low trading volume and limited liquidity.
- Higher susceptibility to fraud or manipulation compared to regulated exchanges.
- Difficulty in obtaining accurate and timely financial data for valuation and analysis.
- Challenges in raising capital due to reduced investor confidence and market access.
- Verify any available financial statements directly from the company or third-party sources.
- Research management's background and track record beyond what is publicly stated.
- Assess the company's business model and competitive landscape thoroughly, given limited data.
- Understand the regulatory environment for OTC markets and the specific 'OTC Other' tier.
- Evaluate the company's ability to generate revenue and manage its negative profit margin.
- Look for any news or press releases from reliable sources that might shed light on operations.
- Consider the potential for delisting or further restrictions on trading.
- Development and commercialization of tangible products (Binovi Touch, Pro, Coach, Academy).
- Identified CEO (Jatinder Dhaliwal) and a physical headquarters in Vancouver, Canada.
- Clear business description focused on a specific healthcare niche (visual and neuro-cognitive processing).
- Ongoing product development pipeline (Binovi Agile, Binovi Connect).
- International market presence in Canada, the U.S., and other regions.
Binovi Technologies Corp. Healthcare Stock: Key Questions Answered
What specific visual perception disorders does Binovi Technologies Corp.'s technology address?
Binovi Technologies Corp. focuses on developing solutions for a range of visual perception disorders, which can include conditions affecting visual processing, eye-hand coordination, depth perception, and oculomotor skills. Its products, such as Binovi Touch, are designed for vision therapy and training, aiming to remediate these disorders through structured exercises. Binovi Pro allows professionals to manage and assign protocols tailored to specific patient needs, while Binovi Coach guides users through their activities. The company's technology is applied in contexts ranging from clinical therapy for developmental vision issues to performance enhancement in sports vision training, indicating a broad application in improving visual function and cognitive processing related to sight. The goal is to enhance the brain's ability to interpret and react to visual information.
How does Binovi Technologies Corp. plan to achieve profitability given its current financial metrics?
Binovi Technologies Corp. currently faces a significant negative profit margin of -8790.2%, indicating that its operating expenses heavily outweigh its revenue. However, its gross margin of 70.7% suggests that the core product sales are profitable before considering overheads. Achieving overall profitability would likely involve scaling its operations to increase revenue significantly while carefully managing its operating costs. Key strategies could include successful commercialization of its development pipeline, particularly Binovi Connect, to expand its customer base and recurring revenue streams. Increased market penetration in professional vision care and international markets would also contribute to higher sales volumes. Additionally, optimizing operational efficiency and potentially securing further funding to bridge the gap until sustainable revenue growth is achieved are critical steps towards improving its bottom line.
What are the implications of Binovi Technologies Corp.'s 'OTC Other' listing for investors?
Binovi Technologies Corp.'s classification as 'OTC Other' on the OTC market carries several implications for investors. This tier is characterized by companies that do not meet the reporting standards of higher exchanges or even other OTC tiers, and in Binovi's case, its disclosure status is 'Unknown.' This means investors have limited access to comprehensive and timely financial information, making thorough due diligence challenging. The stock is likely to have very low liquidity, leading to wide bid-ask spreads and potential difficulty in buying or selling shares at desired prices. Such an environment can also be more susceptible to price volatility and manipulation. Investors typically face higher risks with 'OTC Other' stocks due to reduced transparency, less stringent regulatory oversight, and potential for limited analyst coverage, requiring a high degree of independent research and risk tolerance.
How does Binovi Technologies Corp.'s small employee base impact its operational capabilities and growth prospects?
With only 7 employees, Binovi Technologies Corp. operates with a lean structure, which can offer agility and lower fixed costs. However, this small employee base also presents significant implications for its operational capabilities and growth prospects. A limited team may face challenges in simultaneously managing extensive research and development, manufacturing, marketing, sales, customer support, and administrative functions across Canada, the U.S., and internationally. Scaling operations, penetrating new markets, or rapidly commercializing new products like Binovi Agile and Binovi Connect could be constrained by human capital limitations. While a small team can be efficient, it also means a higher reliance on each individual, and any key personnel changes could have a disproportionate impact on the company's trajectory and ability to execute its strategic initiatives effectively.
What are the key factors to evaluate for BNVIF?
Binovi Technologies Corp. (BNVIF) holds an AI score of 54/100 (moderate). Not financial advice.
How frequently does BNVIF data refresh on this page?
BNVIF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BNVIF's recent stock price performance?
Binovi Technologies Corp. (BNVIF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized product suite for visual and neuro-cognitive processing disorders. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BNVIF overvalued or undervalued right now?
Valuing Binovi Technologies Corp. (BNVIF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived solely from the provided source data. No external information or speculative content has been included. Specific details regarding CEO background and track record were not available in the source and are noted as such. Competitor information was not provided in the source data.